
Results
2
2 companies
BioGaia
Market Cap: SEK 11.8b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 117.10
7D
1.3%
1Y
17.3%
Saniona
Market Cap: SEK 1.6b
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 11.83
7D
-7.5%
1Y
-15.9%